Is Mainpointe Pharmaceuticals FDA approved?

Mainpointe Pharmaceuticals holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Mainpointe Pharmaceuticals make?

1 product is listed under Mainpointe Pharmaceuticals in the openFDA NDC Directory, most often as tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Mainpointe Pharmaceuticals

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 1
Live patents: 2
Countries: 0

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
9066942	TUXARIN ERchlorpheniramine maleate; codeine phosphate	use	Jan 2032
9107921	TUXARIN ERchlorpheniramine maleate; codeine phosphate	product	Jan 2032

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Tuxarin	codeine phosphate and chlorpheniramine maleate	tablet, extended release, oral	71269-040NDA

Enquiry

Common questions

Is Mainpointe Pharmaceuticals FDA approved?: Mainpointe Pharmaceuticals holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Mainpointe Pharmaceuticals make?: 1 product is listed under Mainpointe Pharmaceuticals in the openFDA NDC Directory, most often as tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.